US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 35.600
  • -1.700-4.56%
Close Nov 29 13:00 ET
  • 35.600
  • 0.0000.00%
Post 13:02 ET
979.03MMarket Cap-8470P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LENZ Therapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.46
-0.38
+0.08
Beat Est.
--
+48.61%
+18.26%
Analyst Rating
Strong Buy

Nov 30, 2024

LENZ Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

LENZ Therapeutics Earnings Reports

  • LENZ Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 07:37 ET

  • LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 6 07:27 ET

  • LENZ Therapeutics | 10-Q: Quarterly report

    Aug 14 16:21 ET

  • LENZ Therapeutics | 8-K: LENZ Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 14 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data